Skip to content
Back to Investors
FI

Flerie Invest

Venture Capital

Flerie Invest is a biotech and pharma investor managing a portfolio of companies across multiple global markets.

Portfolio

1

companies

By category

  • AI/ML£50.0M

By location

  • Cambridge£50.0M

Portfolio companies

Microbiotica

Microbiotica

Microbiotica develops microbiome-based therapeutics and precision biomarkers.


Team

Carl-Johan Spak

Carl-Johan Spak

Senior Advisor

Carl-Johan serves as a senior advisor at Flerie Invest and holds multiple board roles across various pharmaceutical companies.

LinkedIn
Thomas Eldered

Thomas Eldered

Founder

Thomas is the founder and executive chairman of Flerie Invest. He previously served as chief executive officer of Recipharm AB and chairman of Cobra Biologics.

LinkedIn

Recent investments

Series B
£50.0M

The financing round was co-led by Tencent and Flerie Invest to support Phase 1b clinical studies and pipeline expansion.

"This major fundraise is a substantial validation of both our team and our world-leading technology. We are fortunate to have the support from new and current investors who have recognised the importance of the microbiome's therapeutic potential and Microbiotica's unique capabilities."
— Mike Romanos, Co-Founder and CEO